|By PR Newswire||
|March 6, 2014 11:37 AM EST||
NEW YORK, March 6, 2014 /PRNewswire/ --
Editor Note: For more information about this release, please scroll to bottom.
Today, Analysts Review released its analysts' notes regarding Rockwood Holdings, Inc. (NYSE: ROC), Methanex Corp. (NASDAQ: MEOH), Albemarle Corp. (NYSE: ALB), PolyOne Corporation (NYSE: POL), and Amyris, Inc. (NASDAQ: AMRS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Rockwood Holdings, Inc. Analyst Notes
On February 18, 2014, Rockwood Holdings, Inc. (Rockwood) announced that its Board of Directors has declared a quarterly cash dividend in the amount of $0.45 per share. The Company informed that the dividend is payable on March 18, 2014 to all common stockholders of record at the close of business on March 3, 2014. The full analyst notes on Rockwood Holdings, Inc. are available to download free of charge at:
Methanex Corp. Analyst Notes
On February 27, 2014, Methanex Corp.'s (Methanex) stock increased 3.26% to end the day at $69.37, compared to the previous day's closing price of $67.18. The Company's stock rose 6.97% over the past three trading days, compared to the Nasdaq Composite which gained 0.60% during the same trading period. The full analyst notes on Methanex Corp. are available to download free of charge at:
Albemarle Corp. Analyst Notes
On February 25, 2014, Albemarle Corp. (Albemarle) reported that its Board of Directors has announced a quarterly dividend of c.$0.28 per share, representing an increase of c.15% over the previous quarterly dividend of $0.24. The Company stated that the dividend is payable on April 1, 2014 to shareholders of record at the close of business on March 14, 2014. Albemarle added that the new annualized rate is $1.10. According to the Company, this announcement marks the 20th consecutive year of dividend increases. President and CEO Luke Kissam, commented, "We are proud of our long history of dividend growth and expect future financial performance to allow this trend to continue." The full analyst notes on Albemarle Corp. are available to download free of charge at:
PolyOne Corporation Analyst Notes
On February 10, 2014, PolyOne Corp. (PolyOne) announced the addition of new capabilities to its OnColor™ HC Plus portfolio. According to the Company, these expanded offerings add medical-grade LDPE, nylon, PEBA, PS and PVC to the globally available palette of specialty healthcare colorants, and are pre-certified to meet or exceed biocompatibility requirements for ISO 10993 and/or USP Class VI protocols. James Petrie, Marketing Director for PolyOne Color and Additives, said, "This expansion of the OnColor HC Plus portfolio reinforces our commitment to the healthcare industry and adds new alternatives for customers who seek to streamline their qualification, testing and supply chain management processes." The full analyst notes on PolyOne Corporation are available to download free of charge at:
Amyris, Inc. Analyst Notes
On February 25, 2014, Amyris, inc. (Amyris) and International flavors & Fragrances Inc. (IFF) announced the completion of the first phase of their collaboration in developing a specific set of renewable fragrance ingredients. Amyris stated that both companies have reached an agreement to move forward with the second phase of development. Commenting on the partnership, John Melo, Amyris President and CEO, commented, "We are extremely pleased with the success in our collaboration with IFF and are optimistic about the prospect for scaling up new fragrance compounds using our technology platform." The Company informed that under the terms of the multi-year agreement, IFF will have exclusive rights to the renewable fragrance ingredients developed for applications in the flavors and fragrances sector, and Amyris will have exclusive rights in other sectors." The full analyst notes on Amyris, Inc. are available to download free of charge at:
About Analysts Review
We provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] AnalystsReview.com.
- For any urgent concerns or inquiries, please contact us at compliance [at] AnalystsReview.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] AnalystsReview.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the Procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Analysts Review